Infant DHA ingredient sales will expand through 2036, with algal DHA holding 64.0% share in 2026. Infant formula accounts for 72.0% of application demand. The market is sized at USD 0.58 billion in 2026 and is set to reach USD 1.17 billion by 2036 as formula fortification widens.